Product Name : Pomalidomide
CAS : 19171-19-8
Molecular Formula : C13H11N3O4
Molecular Weight : 273.25
Pharmaceutical Grade : IH
Therapeutic Category : Immunomodulator.
Global calcium is one of the leading manufacturers and exporters of Pomalidomide CAS No. 19171-19-8, API, (Active Pharmaceutical Ingredient). We support the customers with exhaustive documentation. As a USDMF & EU-GMP certified global company and an established hallmark for pharmaceutical standards, global calcium has stood the test of time since its inception in 1979.
As manufacturer of Pomalidomide we hereby state the following facts about the drug:
Pomalidomide is indicated for the:
treatment of multiple myeloma and certain cases of Kaposi sarcoma.
Mechanism of action
Pomalidomide directly inhibits angiogenesis and myeloma cell growth. This dual effect is central to its activity in myeloma, rather than other pathways such as TNF alpha inhibition, since potent TNF inhibitors including rolipram and pentoxifylline do not inhibit myeloma cell growth or angiogenesis.[16]
Pomalidomide works as a cereblon E3 ligase modulator.
Global calcium is a leading manufacturer of this drug. We manufacture this pharmaceutical drug and make it available to domestic and overseas market.
